Viewing Study NCT03605056


Ignite Creation Date: 2025-12-24 @ 11:18 PM
Ignite Modification Date: 2025-12-25 @ 8:58 PM
Study NCT ID: NCT03605056
Status: UNKNOWN
Last Update Posted: 2018-07-30
First Post: 2018-07-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase 2 Trial of Chidamide-Lenalidomide-Dexamethasone(CRD) Regimen in R/R MM
Sponsor: Peng Liu
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module